期刊文献+

86例膜性肾病回顾性分析及对CD_4^+CD_(25)^+调节性T细胞的初步研究 被引量:4

Retrospective Analysis of 86 Cases with Membranous Nephropathy and Research on Amount of CD_4^+CD_(25)^+ Regulatory T cells
在线阅读 下载PDF
导出
摘要 目的:回顾性总结、分析86例膜性肾病患者的临床表现、实验室检查及肾活检病理的特点及相互联系,认识膜性肾病的发病和流行病学特点。通过对特发性膜性肾病(idiopathic membranous nephropathy,IMN)患者和正常人外周血CD4+CD2+5调节性T细胞(Treg细胞)数量的检测,了解Treg在IMN患者外周血的变化规律,探讨其在IMN发病中的作用。方法:2004年3月~2008年12月间病理确诊为膜性肾病患者86例,分析患者一般资料、病理类型和临床特征。选择2007年~2008年IMN患者10例,随机选取与IMN患者年龄相匹配的健康志愿者10例,检测所有对象外周血Treg细胞数量。结果:(1)86例膜性肾病患者,其中IMN68例,占80%,4例患者随访后确诊为恶性肿瘤;继发性膜性肾病18例(其中乙肝病毒相关性肾炎5例,狼疮性肾炎4例,移植肾肾小球肾炎1例),占20%。(2)IMN免疫荧光以IgG沉积为主,乙肝病毒相关性肾炎C1q沉积较IMN多(P<0.05),并均存在HBsAg沉积,与IMN相比狼疮性肾炎C1q沉积明显增多,C4也多于IMN(P<0.05)。(3)病理分期分布特点:Ⅱ期膜性肾病多见。(4)IMN患者治疗前外周血Treg细胞占CD4+淋巴细胞的百分比为(7.46±0.94)%,正常对照组为(6.54±1.0)%。结论:(1)根据病因分为IMN及继发性膜性肾病两种,男性发病率大于女性,中老年多发,继发性膜性肾病的年龄及性别分布根据病因的不同而有所不同,临床表现均以肾病综合征表现为主;IMN发病率明显大于继发性膜性肾病。(2)免疫荧光检查:IMN以IgG及C3沉积为主,乙肝病毒相关性肾炎均存在乙肝表面抗原,狼疮性肾炎与乙肝病毒相关性肾炎的C1q沉积较特发性膜性肾病明显增多(P<0.05)。(3)IMN患者外周血Treg细胞数量较正常人增多。 Objective:To retrospectively analyze clinical manifestations,laboratory examination and pathological features of 86 patients with membranous nephropathy.Amount of CD^+4CD^+25 regulatory T cells (Treg) in peripheral blood were detected to explore their roles on idiopathic membranous nephropathy (IMN).Methods:Eighty-six patients with membranous nephropathy were included from March 2004 to December 2008 in our hospital and patients' general data,pathological types and clinical features were analyzed.Amount of Treg was detected by Flow Cytometry.Treg number of 10 patients selected with IMN was compared with age-matched 10 healthy volunteers.Results:(1)68 patients were diagnosed as IMN accounting for 80% and 4 patients as malignant tumor after follow-up;18 cases were secondary membranous nephropathy (including 5 cases caused by hepatitis B virus-associated glomerulonephritis,and 4 cases by lupus nephritis and one case of onset after renal transplantation) accounting for 20%.(2)IgG deposits along capillary walls in IMN and C1q was much more in hepatitis B virus-associated glomerulonephritis than that in IMN (P〈0.05),Compared with IMN,significantly increased C1q and C4 deposition in lupus nephritis (P〈0.05).(3)Stage Ⅱ membranous nephropathy was more common.(4)Treg cells accounted for(7.46 ±0.94)% of the percentage of CD+4 lymphocytes in IMN patients with pre-treatment;while it was(6.54±1.0)% in the normal control group.Conclusion:(1)Membranous nephropathy can be divided into IMN and secondary membranous nephropathy based on the causes.Peak occurrence of IMN is in middle-aged males.Secondary membranous nephropathy shows different clinical manifestations according to age and sex distribution of the different causes.Incidence of this disease in IMN patients is significantly more than that of secondary membranous nephropathy.(2)IgG and C3 deposits mainly in IMN.In addition to IgG and C3 deposition,hepatitis B surface antigen exists in hepatitis B virus associated glomerulonephritis.C1q deposition is much more in Lupus nephritis patients and patients with hepatitis B virus-associated glomerulonephritis than that in IMN patients(P〈0.05).(3)Treg number of IMN patients increased significantly,compared with that of normal controls.
出处 《中国中西医结合肾病杂志》 2009年第12期1063-1065,I0013,共4页 Chinese Journal of Integrated Traditional and Western Nephrology
基金 吉林省科技厅基金资助项目(No.20080439-1)
关键词 膜性肾病 肾脏病理 TREG细胞 Membranous nephropathy Renal pathology CD4^+CD^25+ regulatory T cells
作者简介 通讯作者
  • 相关文献

参考文献8

  • 1Wolf D, Hochegger K, Wolf Am, et al. CD4^+ CD25^+ regulatory T cells inhibit experimental Anti glomerular basement membrane glomerulonephritis in mice. J Am Sol Nephrol, 2005, 16 ( 5 ) : 1360 - 1370.
  • 2Ruggenenti P, Chiurchiu C, Abbate M, et al. Rituximab for idiopathic membranous nephropathy: who can benefit. Clin J Am Soc Nephrol,2006, 1(4) :738 748.
  • 3苗里宁,顾华,卢雪红,李秀霞,高风香.氯沙坦对老年糖尿病肾病患者尿蛋白的治疗作用研究[J].中国老年学杂志,2001,21(2):109-110. 被引量:6
  • 4周柱亮.乙型肝炎病毒相关性膜性肾病的治疗[J].中国中西医结合肾病杂志,2008,9(4):283-284. 被引量:2
  • 5Austim HA, IIIei GG. Membranous lupus nephritis. Lupus, 2005,14 (1):65-71.
  • 6Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self tolerance maintained by activated T cells expressing IL-2 receptor alpha chains (CD25). Breakdown of a single mechanism of self-tolerance cauls various autoimmune diseases. Journal of Immunology, 1995,155(3) : 1151-1164.
  • 7Liu WH, Zhou XY. CD127 expression inversely correlates with Foxp3 and suppressive function of human CD46+CD25^+ Treg cells. J Exp Med,2006,203(7) : 1701 - 1711.
  • 8Hori S, Nomura T, Sakaguchi S. Control of regulatory T cells development by the transcription factor Foxp3. Science, 2003, 299(56):1057-1061.

二级参考文献2

共引文献6

同被引文献37

  • 1王瑞石,刘志红.膜性肾病的发病机制[J].肾脏病与透析肾移植杂志,2006,15(2):161-166. 被引量:20
  • 2秦卫松,刘志红,曾彩虹,郑春霞,贾忠辉,王生余,黎磊石.雷公藤甲素对Heymann肾炎模型足细胞病变的影响[J].肾脏病与透析肾移植杂志,2007,16(2):101-109. 被引量:97
  • 3du tktf- Vereijken PW, Branten AJ, Wetzels JF. Idiopathicmem-branous nephropathy: outline and rationale of a treatment strategy. Am J Kidney Dis,2005,46(6) : 1012 - 1029.
  • 4Troyanov S, Wall CA, Miller JA, et al. Idiopathic membranous nephropathy:definition and relevance of a partial remission. Kidney Int,2004,66(3) : 1199 - 1205.
  • 5Waldman M. Austin HA 3rd. Controversies in the treatment of idiopathic membranous nephropathy. Nat Bey Nephrel, 2009,5 (8) :469 - 479.
  • 6Torres A, Dominguez-Gil B, Carreno A, et al. Conservative versus immunosuppressive treatment of patients with idiopathic membranous nephropathy. Kidney Int, 2002, 61: 219- 227.
  • 7Arikanl H, Kocl M, Cakalagaoglu F, et al. Tacrolimus rescue therapy in resistant or relapsing cases of primary glomerulonephritis.J Nephrol, 2008, 21: 713-721.
  • 8Gx.rrrenos lli, Katopodis KP, Passadakis P, et al, Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatm.
  • 9Dede F, Ayili D, Sahiner S. Effective treatment administration of cyclophosphamide in membranous nephropathy.J Nephrol, 2008, 21: 560-565.
  • 10Miao LN, SunJ, Yuan H, et al. Combined therapy of lowdose tacrolimus and prednisone in nephrotic syndrome with slight mesangial proliferation. Nephron, 2006 , 11: 449- 454.

引证文献4

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部